The submission references Exact Sciences Corporation (NASDAQ: EXAS), a massive biotechnology firm with ~$2.76B in 2024 revenue and ~7,000 employees. While the user submission ('ShadowHunter') was low-effort and lacked detail, independent verification confirms the project is the established market leader in non-invasive colorectal cancer screening (Cologuard). The score reflects the company's exceptional real-world utility, massive audience reach (16M+ tests), and proven traction, adjusted for the lack of submission quality and external verification reliance.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline